Cancer Management and Research
Volume 13, 2021 - Issue
Open access
104
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Combination of 99mTc-Labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the Prediction of Early Response After Carbon Ion Therapy in Prostate Cancer: A Non-Randomized Prospective Pilot Study
Ping Li1 Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China
, Chang Liu4 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;5 Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Fudan University, Shanghai, People’s Republic of China;6 Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai, People’s Republic of China
, Shuang Wu2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;7 Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, People’s Republic of China
, Lin Deng2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;8 Department of Radiology, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of China
, Guangyuan Zhang2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;8 Department of Radiology, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of China
, Xin Cai1 Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China
, Silong Hu4 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;5 Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Fudan University, Shanghai, People’s Republic of China;6 Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai, People’s Republic of China
, Jingyi Cheng2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;6 Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai, People’s Republic of China;9 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, People’s Republic of China
, Xiaoping Xu4 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;5 Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Fudan University, Shanghai, People’s Republic of China;6 Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai, People’s Republic of Chinahttps://orcid.org/0000-0001-9656-6233
, Bin Wu2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;10 Department of Radiology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, People’s Republic of China
, Xiaomao Guo2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of China;7 Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, People’s Republic of China
, Yingjian Zhang4 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;5 Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Fudan University, Shanghai, People’s Republic of China;6 Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai, People’s Republic of China
, Shen Fu5 Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Fudan University, Shanghai, People’s Republic of China;11 Department of Radiation Oncology, Shanghai Concord Cancer Hospital, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
& Qing Zhang1 Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Radiation Oncology, Shanghai, People’s Republic of China;3 Shanghai Engineering Research Center of Proton and Heavy ion Radiation Therapy, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
show all
Pages 2191-2199
|
Published online: 03 Mar 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.